ARCHIVES

Retraction Based On Data Given To Duke Last November, But Apparently Disregarded

This article is from The Cancer Letter archive.

Vol. 36 No. 39 | October 29, 2010

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

July 30, 2010

Five New Members Appointed To The National Cancer Advisory Board

July 8, 2011

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

December 27, 2013

Wilms’ Tumor Survivors At High Risk Of Heart Failure

April 27, 2001

FTC Report Disagrees With Key Provision Of Biologics Bill Backed By Companies

June 12, 2009

NCI Advisory Group, Other Cancer Meetings

August 16, 1985